Internal Medicine, Infectious Disease · Ft Lauderdale, FL
NPI
1619973377
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2151 E Commercial Blvd Ste 203
Ft Lauderdale, FL, 33308
Phone (954) 489-2260
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
349 services
Medicare patients, 2024
132
Average age 74
Drug cost, 2024
$9.0M
4,249 prescriptions
Company payments, 2025
$2,500
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ledya Cobian was code 99214 (office e&m - established), 263 times for 109 patients. In total Ledya Cobian billed 349 services in 11 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 263 | 109 | $95.94 | $25K |
| 99204 Office E&M - New | Office | 49 | 49 | $134.29 | $6,580 |
By year: 2022 $33K for 367 services; 2023 $30K for 332 services; 2024 $34K for 349 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 31 | 18 | $8.40 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Ledya Cobian prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 796 prescriptions and refills. In total Ledya Cobian wrote 4,249 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 796 | 802 | 95 | $3.2M |
| Tivicay Dolutegravir Sodium | 305 | 305 | 36 | $731K |
| Descovy Emtricitabine/Tenofov Alafenam | 280 | 285 | 33 | $641K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 259 | 261 | 32 | $1.2M |
| Prezcobix Darunavir/Cobicistat | 190 | 190 | 19 | $476K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 125 | 125 | 13 | $497K |
| Juluca Dolutegravir/Rilpivirine | 100 | 100 | 11 | $358K |
| Isentress Raltegravir Potassium | 93 | 95 | Under 11 | $189K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 92 | 92 | Under 11 | $330K |
| Azithromycin Generic | 83 | 87 | 20 | $937 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 81 | 81 | 11 | $304K |
| Darunavir Generic | 79 | 79 | Under 11 | $62K |
| Pifeltro Doravirine | 73 | 73 | Under 11 | $127K |
| Dovato Dolutegravir Sodium/Lamivudine | 71 | 79 | Under 11 | $233K |
| Ritonavir Generic | 63 | 83 | Under 11 | $13K |
Brand drugs: 2,662 claims; generic drugs: 1,587 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ledya Cobian $2,500 ($2,500 in general payments such as food, travel and fees) from 10 companies. The largest payer was ViiV Healthcare Company with $916.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 46 | $916 |
| Gilead Sciences, Inc. GILD | 31 | $750 |
| Insmed, Inc. INSM | 18 | $328 |
| Paratek Pharmaceuticals, Inc. | 8 | $180 |
| Merck Sharp & Dohme LLC MRK | 5 | $124 |
| Shionogi Inc 4507.T | 2 | $53.85 |
| Abbvie Inc. ABBV | 2 | $44.08 |
| EMD Serono, Inc. MRK.DE | 1 | $36.92 |
| Theratechnologies Inc. THTX | 1 | $34.67 |
| Cumberland Pharmaceuticals, Inc. CPIX | 2 | $32.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.